Khasraw, M., Singh, K., Foster, M., Violette, M., Corcoran, A., Hotchkiss, K., … Fecci, P. (2025). A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma. Research Square. https://doi.org/10.21203/rs.3.rs-5822396/v1

Khasraw, Mustafa, Kirit Singh, Matthew Foster, Marlene Violette, Anna Corcoran, Kelly Hotchkiss, Chelsea Railton, et al. “A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma.” Research Square, 2025. https://doi.org/10.21203/rs.3.rs-5822396/v1.

Khasraw M, Singh K, Foster M, Violette M, Corcoran A, Hotchkiss K, et al. A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma. Research Square. 2025.

Khasraw, Mustafa, et al. “A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma.” Research Square, 2025. Epmc, doi:10.21203/rs.3.rs-5822396/v1.

Khasraw M, Singh K, Foster M, Violette M, Corcoran A, Hotchkiss K, Railton C, Blandford E, Blethen K, Thomas E, Ashley D, Desjardins A, Friedman H, Johnson M, Friedman A, Keir S, Buckley E, Herndon J, McLendon R, Sampson J, Calabrese E, Lopez G, Grant G, Patel A, Gregory S, Li C-Y, Fecci P. A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma. Research Square. 2025.